Musabaev, Erkin
Ismailov, Umed
Ibadullaeva, Nargiz
Khikmatullaeva, Aziza
Norbaev, Ilham
Primov, Umar
Ahrarova, Dilorom
Sharapov, Saidkhon
Yusupov, Ulugbek
Latipov, Renat
Funding for this research was provided by:
GSK’s Investigator Sponsored Studies (eTrack Number 208662)
Article History
Received: 31 January 2023
Accepted: 26 May 2023
First Online: 10 June 2023
Declarations
:
: The authors declare that they have no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results. Written informed consent was collected from all participants. Anonymity and confidentiality were confirmed.
: Study protocol was approved by the Ethics Committee of the Ministry of Health of the Republic of Uzbekistan. The parents or legal guardians of participating children provided written consent after being informed about the study goals and objectives and the conditions for and potential benefits of their children’s participation.
: All authors consented to submission for publication.